Bruce & Co’s Bausch Health BHC Stock Holding History

Bruce & Co’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$611K	Hold	124,000	–	–	0.17%	38
2026 Q1	$670K	Hold	124,000	–	–	0.19%	37
2025 Q4	$862K	Sell	124,000 -47,000	-27%	-$309K	0.27%	33
2025 Q3	$1.1M	Hold	171,000	–	–	0.34%	31
2025 Q2	$1.14M	Hold	171,000	–	–	0.37%	31
2025 Q1	$1.11M	Hold	171,000	–	–	0.35%	28
2024 Q4	$1.38M	Sell	171,000 -279,000	-62%	-$2.3M	0.44%	27
2024 Q3	$3.67M	Sell	450,000 -100,000	-18%	-$659K	1.07%	21
2024 Q2	$3.83M	Sell	550,000 -94,000	-15%	-$711K	1.26%	19
2024 Q1	$6.83M	Hold	644,000	–	–	2.27%	15
2023 Q4	$5.16M	Sell	644,000 -206,000	-24%	-$1.5M	1.8%	16
2023 Q3	$6.99M	Sell	850,000 -75,780	-8%	-$653K	2.38%	14
2023 Q2	$7.42M	Hold	925,780	–	–	2.08%	16
2023 Q1	$7.5M	Sell	925,780 -5,220	-0.6%	-$41.9K	2.04%	16
2022 Q4	$5.85M	Hold	931,000	–	–	1.51%	17
2022 Q3	$6.41M	Sell	931,000 -450,000	-33%	-$3.13M	1.76%	16
2022 Q2	$11.5M	Hold	1,381,000	–	–	2.71%	14
2022 Q1	$31.6M	Hold	1,381,000	–	–	6.45%	7
2021 Q4	$38.1M	Hold	1,381,000	–	–	7.62%	4
2021 Q3	$38.5M	Sell	1,381,000 -45,000	-3%	-$1.28M	8.17%	3
2021 Q2	$41.8M	Sell	1,426,000 -1,000	-0.1%	-$30.3K	7.98%	3
2021 Q1	$45.3M	Hold	1,427,000	–	–	8.49%	2
2020 Q4	$29.7M	Hold	1,427,000	–	–	5.72%	7
2020 Q3	$22.2M	Buy	1,427,000 +65,000	+5%	+$1.12M	4.59%	11
2020 Q2	$24.9M	Buy	1,362,000 +50,000	+4%	+$881K	5.41%	10
2020 Q1	$20.3M	Buy	1,312,000 +171,000	+15%	+$4.12M	4.68%	9
2019 Q4	$34.1M	Buy	1,141,000 +150,000	+15%	+$3.9M	6.66%	4
2019 Q3	$21.7M	Buy	991,000 +95,000	+11%	+$2.17M	4.5%	8
2019 Q2	$22.6M	Sell	896,000 -75,000	-8%	-$1.78M	4.82%	8
2019 Q1	$24M	Buy	971,000 +11,000	+1%	+$263K	4.68%	8
2018 Q4	$17.7M	Buy	960,000 +50,000	+5%	+$1.19M	3.77%	11
2018 Q3	$23.3M	Buy	910,000 +50,000	+6%	+$1.14M	4.52%	9
2018 Q2	$20M	Buy	860,000 +5,000	+0.6%	+$103K	3.98%	11
2018 Q1	$13.6M	Buy	855,000 +256,000	+43%	+$4.76M	2.84%	16
2017 Q4	$12.4M	Buy	599,000 +18,000	+3%	+$285K	2.7%	16
2017 Q3	$8.32M	Hold	581,000	–	–	1.86%	17
2017 Q2	$10.1M	Buy	+581,000	New	+$6.96M	2.3%	18

Other funds holding BHC

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bruce & Co's BHC Position: Q2 2026 in Review

Bruce & Co held its Bausch Health (BHC) position steady in Q2 2026 at 124,000 shares worth $611K. The position accounts for 0.17% of the portfolio, ranked #38.

Bruce & Co first reported a position in BHC in Q2 2017 and has held it in 37 quarters since. The position peaked at $45.3M in Q1 2021. 222 funds tracked by Wall St. Rank hold BHC as of Q2 2026.

Bruce & Co held 124,000 shares of Bausch Health worth $611K as of Q2 2026.
Bruce & Co left its Bausch Health share count unchanged in Q2 2026.
Bausch Health made up 0.17% of Bruce & Co's portfolio in Q2 2026, its #38 holding.
Bruce & Co first reported a position in Bausch Health in Q2 2017 and has held it in 37 quarters since.
Bruce & Co's Bausch Health position peaked at $45.3M in Q1 2021.
222 funds tracked by Wall St. Rank held Bausch Health as of Q2 2026.

Based on Bruce & Co's 13F filing for Q2 2026, filed 14 Aug 2026.